Open AccessTreatment with pegylated interferon alpha 2b and ribavirin in patients unresponsive to previous treatments with standard interferon as monotherapy or combined with ribavirin
Author(s) -
Fernando Carnicer,
Pedro Zapater,
Alicia Gutiérrez,
A. H. Perez Garcia,
Fernando J. Ruiz,
M. González López
Publication year - 2005
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.4321/s1130-01082005000500002
Subject(s) - ribavirin , medicine , pegylated interferon , gastroenterology , alpha interferon , viremia , interferon , hepatitis c , hepatitis c virus , chronic hepatitis , virus , immunology
Little information is available on the effect of pegylated interferon (PEG) and ribavirin (RBV) in patients with chronic hepatitis due to virus C (CHC) who were non-responders to previous treatment.